16 April 2026 MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
20 January 2026 Two Retina International Abstracts Accepted For Presentation at the ARVO 2026 Annual Meeting